Tactile Cueing for Parkinson's Disease
(cueing Trial)
Trial Summary
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications, but you cannot participate if you are currently using dopamine-blocking agents or cholinesterase inhibitors.
What data supports the effectiveness of tactile cueing treatment for Parkinson's Disease?
Research shows that both open-loop and closed-loop tactile cueing can improve turning and reduce freezing in people with Parkinson's Disease. Additionally, using external sensory cues in rehabilitation can extend the benefits of physical therapy, helping patients maintain improvements in daily activities and motor skills.12345
Is tactile cueing safe for humans?
How is tactile cueing treatment different from other treatments for Parkinson's disease?
Tactile cueing treatment for Parkinson's disease is unique because it uses touch-based signals to help improve walking patterns, unlike other treatments that often rely on visual or sound cues. This approach can be personalized to the individual's walking rhythm, potentially offering better efficiency and retention of improved gait patterns.12689
What is the purpose of this trial?
The purpose of the study is to determine the effects of a novel, personalized, tactile cueing system on gait automaticity. The researchers hypothesized that step-synchronized tactile cueing will reduce prefrontal cortex activity (improve automaticity) and improve gait variability (as well as gait speed). The researchers predict that improved automaticity with improved gait variability will be associated with increased activation of other than prefrontal cortical areas while walking (i.e., sensory-motor). To determine the effects of cueing, 60 participants with PD from will be randomized into one, of two, cueing interventions: 1) personalized, step-synchronized tactile cueing and 2) tactile cueing at fixed intervals as an active control group. In addition, the researchers will explore the feasibility and potential benefits of independent use of tactile cueing during a week in daily life for a future clinical trial.This project will characterize the cortical correlates of gait automaticity, the changes in gait automaticity with cueing in people with Parkinson's Disease, and how these changes translate to improvement in gait and turning. The long-term goal is to unravel the mechanisms of impaired gait automaticity in Parkinson's Disease.
Research Team
Martina Mancini, PhD
Principal Investigator
Oregon Health and Science University
Eligibility Criteria
This trial is for people with Parkinson's Disease who can walk and follow instructions. They must be diagnosed by a specialist, not have other serious nervous system issues besides PD, and be at specific stages of the disease where symptoms are moderate.Inclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants are randomized into one of two cueing interventions: personalized, step-synchronized tactile cueing or tactile cueing at fixed intervals.
Follow-up
Participants are monitored for retention of gait and turning improvements with a third week of continuous monitoring.
Extension
Exploration of the feasibility and potential benefits of independent use of tactile cueing during a week in daily life.
Treatment Details
Interventions
- Fixed tactile cueing
- Personalized tactile cueing
Find a Clinic Near You
Who Is Running the Clinical Trial?
Oregon Health and Science University
Lead Sponsor
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Collaborator